LS
Les Sulewski Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
8
Avg Return
Past Year
Past Year
9.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $18 |
206%
upside
| 1 | +6.5% |
0
%
| 5 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $17 |
5%
upside
| 1 | -13% |
0
%
| 2 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $42 |
25%
upside
| 3 | +25% |
0
%
| 18 Feb ‘26 3 months ago |
|
|
|
Hold
Maintained
| $8 |
60%
upside
| 1 | – |
–
| 7 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $28 |
23%
upside
| 1 | +11% |
0
%
| 7 Nov ‘25 7 months ago |
|
|
|
Buy
Maintained
| $48 |
40%
upside
| 1 | -12% |
0
%
| 7 Nov ‘25 7 months ago |
|